This compound is a nucleoside phosphoramidite building block used primarily in pharmaceutical and biotechnology research. It features a complex, highly modified nucleoside structure with multiple aromatic rings and a phosphoramidite group.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 1391913-24-8
DMT-2'-O-TBDMS-G(dmf)-CE-phosphoramidite
nucleoside phosphoramidite for oligonucleotide synthesis
DMF-dG Phosphoramidite
nucleoside phosphoramidite building block
N'-[9-[(2R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenyl-methoxy]methyl]-4-[2-cyanoethoxy-(diisopropylamino)phosphanyl]oxy-tetrahydrofuran-2-yl]purin-6-yl]-N,N-dimethyl-acetamidine
Nucleoside phosphoramidite building block
Tert-butyl (5R)-5-amino-3,3-difluoropiperidine-1-carboxylate
pharmaceutical intermediate
Micafungin Impurity H
pharmaceutical impurity reference standard
(2S)-6-amino-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)hexanoic acid hydrochloride
Fmoc-protected lysine for peptide synthesis
Aceclofenac Methyl Ester
Pharmaceutical intermediate for aceclofenac synthesis
5'-O-DMT-N2-DMF-dG
Nucleoside protecting group intermediate
N'-[9-[(2R,3S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-3-fluorooxolan-2-yl]-6-oxo-1H-purin-2-yl]-N,N-dimethylmethanimidamide
BUKKJOTXODUNQK-NTXSMOKRSA-N
CC(C)N(C(C)C)P(OCCC#N)OC1[C@H](O[C@H]([C@H]1F)N2C=NC3=C2N=C(NC3=O)/N=C/N(C)C)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC
—